PRODUCT INFORMATION

 I. TECHNICAL SPECIFICATIONS

Structural / Composition Data

Structure / Formula

Arg–Gly–Asp motif

Molecular Weight

~500–1000 Da (variant dependent)

Appearance

White – Off White Powder

Purity

≥ 95% (HPLC)

Solubility

Soluble in aqueous buffers

Form(s) Available

Lyophilized powder / sterile solution

Stability & Shelf Life

Storage

12 months at 2–8 °C, >24 months at –20 °C

Post-Reconstitution

6-12 months at 2–8 °C

Stability Notes

Protect from light

Quality & Compliance

QC Tests

Pending validation

Intended Use

As instructions

Documentation

Available on request

 II. PREPARATION / RECONSTITUTION

General Guidance

Reconstitute with 1.0 mL sterile water to obtain 100 mg/mL.

Recommendations

Use within 8–12 hours refrigerated.

 III. MECHANISM & BIOLOGICAL FUNCTION

Mechanism of Action

Mimics ECM ligands → binds integrins (αvβ3, α5β1) → promotes adhesion, angiogenesis, and targeted cell delivery.

Biological Claims

• Integrin-mediated targeting
• Cell adhesion & migration
• Angiogenesis induction

 IV. APPLICATIONS

Intended Uses

Targeted drug delivery systems

 V. PACKAGING & PRESENTATION

Available Sizes / Form

Powder Form

100 mg vials

250 mg vials

500 mg vials

1 g vials

Solution Form

1 mL (10% w/v)

5 mL (10% w/v)

10 mL (10% w/v)

20 mL (10% w/v)

Variants

Linear

Cyclic